title: Antitrypanosomal agents: treatment or threat?
authors.forename: Victor Sarli
authors.initials: VS
authors.lastname: Issa
authors.forename: Edimar Alcides
authors.initials: EA
authors.lastname: Bocchi
mesh_terms: D002598:Chagas Cardiomyopathy / Q000188:drug therapy; D014355:Chagas Disease / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D003875:Drug Eruptions / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D015201:Meta-Analysis as Topic; D009547:Nifurtimox / Q000008:administration & dosage / Q000009:adverse effects*; D009593:Nitroimidazoles / Q000008:administration & dosage / Q000009:adverse effects*; D011115:Polyneuropathies / Q000139:chemically induced* / Q000517:prevention & control; D014344:Trypanocidal Agents / Q000008:administration & dosage / Q000009:adverse effects*; D014349:Trypanosoma cruzi / Q000187:drug effects; D014481:United States
chemical_list: D009593:Nitroimidazoles; D014344:Trypanocidal Agents; D009547:Nifurtimox; C009999:benzonidazole